Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Takara Bio Inc. ( (JP:4974) ) has shared an update.
Takara Bio Inc. reported its consolidated financial results for the fiscal year ended March 31, 2025, showing a 3.5% increase in net sales compared to the previous year. Despite the increase in sales, the company experienced a decline in operating and ordinary profits by 24.6% and 23.9%, respectively. The company maintained its dividend payout, reflecting a stable return to shareholders, while forecasting a significant increase in net sales and profits for the next fiscal year.
The most recent analyst rating on (JP:4974) stock is a Hold with a Yen1000.00 price target. To see the full list of analyst forecasts on Takara Bio Inc. stock, see the JP:4974 Stock Forecast page.
More about Takara Bio Inc.
Takara Bio Inc. is a company listed on the Tokyo Stock Exchange, primarily involved in the biotechnology industry. The company focuses on developing and providing innovative products and services in the life sciences sector.
Average Trading Volume: 341,122
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen99.58B
For detailed information about 4974 stock, go to TipRanks’ Stock Analysis page.